Intranasal Lysine‐Aspirin in Aspirin‐Sensitive Nasal Polyposis: A Controlled Trial
Authors:
- 1 August 2005
- journal article
- clinical trial
- Published by Wiley in The Laryngoscope
- Vol. 115 (8) , 1385-1390
Abstract
Objectives/Hypothesis: Intranasal lysine‐aspirin has been used as a method of desensitization in patients with aspirin‐sensitive nasal polyps to control their recurrence and prevent frequent surgical intervention. However, the studies are limited in number, and their design is open to criticisms. Thus, we conducted a controlled trial to study the clinical effectiveness of topical lysine‐aspirin in patients with aspirin‐sensitive nasal polyposis.Study Design: Prospective, randomized, double blind, placebo controlled, crossover trial.Methods: Aspirin‐sensitive patients confirmed by intranasal challenge were enrolled and randomized to receive 16 mg of topical lysine‐aspirin every 48 hours or placebo for 6 months before crossover. Polyp growth and nasal and chest symptoms were monitored using acoustic rhinometry, nasal inspiratory peak flow, peak expiratory flow rate, and a daily diary of symptom scores.Results: Twenty‐two patients were enrolled. After withdrawals and drop outs, data were available on 11 patients for analysis. Multivariate analysis of measured parameters did not reveal a significant clinical benefit to patients receiving topical lysine‐aspirin compared with placebo. Deterioration was similar while on lysine‐aspirin or placebo.Conclusions: This is the first controlled clinical trial of topical desensitization in aspirin‐sensitive nasal polyp patients. Despite the failure to demonstrate clinical benefit, tissue studies have shown a significant improvement at the microscopic level.1 Further work with larger numbers of patients along with conventional treatment may show a clinical improvement in these patients.Keywords
This publication has 12 references indexed in Scilit:
- Leukotriene-Receptor Expression on Nasal Mucosal Inflammatory Cells in Aspirin-Sensitive RhinosinusitisNew England Journal of Medicine, 2002
- An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthmaClinical & Experimental Allergy, 2001
- Effects of lysine-acetylsalicylate (LAS) treatment in nasal polyposis: two controlled long term prospective follow up studiesThorax, 2000
- Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: Long-term outcomesJournal of Allergy and Clinical Immunology, 1996
- Acoustic rhinometry: validation of volume changes following intra-nasal polypectomyClinical Otolaryngology, 1993
- Acoustic rhinometry used as a method to monitor the effect of intramuscular injection of steroid in the treatment of nasal polypsThe Journal of Laryngology & Otology, 1991
- Aspirin-sensitive rhinosinusitis asthma: A double-blind crossover study of treatment with aspirinJournal of Allergy and Clinical Immunology, 1984
- Improvement in aspirin-sensitive asthmatic subjects after rapid aspirin desensitization and aspirin maintenance (ADAM) treatmentJournal of Allergy and Clinical Immunology, 1983
- Aspirin-sensitive asthma: Tolerance to aspirin after positive oral aspirin challengesJournal of Allergy and Clinical Immunology, 1980
- Nasal Polypectomy in Patients With Asthma and Sensitivity to AspirinJAMA Otolaryngology–Head & Neck Surgery, 1979